Guangwei Li: Clinical Trials

1 trial sponsored by Guangwei Li, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Completed 1

Follow Guangwei Li: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Contribution of Pancreatic αcells Function to Blood Glucose Regulation in Chinese Type 2 Diabetics- the Effect of Sitagliptin on Glucagon Secretion, Insulin Secretion and Insulin Resistance in Chinese Type 2 Diabetics
Sitagliptin - Insulin Secretion, Insulin Resistance
Phase 4CompletedGuangwei Li852012-10-012017-05-11

Conditions studied

Insulin Resistance (1)

Interventions

Sitagliptin Phosphate (1)

Countries

China (1)